Drug-related problems in patients with angina pectoris, type 2 diabetes and asthma - Interviewing patients at home

Pharmacy World and Science

Volumn 28, Issue 4, 2006, Pages 239-247

  Haugbølle, Lotte Stig ^a   Sørensen, Ellen Westh ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Angina pectoris; Asthma; Diabetes; DRP; Drug related problems; Home interviews; Medication review; Patient perspective; Type 2 diabetes

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EMCONOR; METFORMIN; NITRATE; STEROID;

ADULT; AGED; ANGINA PECTORIS; ASTHMA; COMPUTER SYSTEM; CONTROLLED STUDY; DENMARK; DRUG INDUCED DISEASE; EXPERIENCE; HEALTH CARE QUALITY; HEART PALPITATION; HUMAN; INTERVIEW; KNOWLEDGE; MAJOR CLINICAL STUDY; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COUNSELING; PERCEPTION; PHARMACY; QUALITATIVE RESEARCH; QUALITY CONTROL; QUESTIONNAIRE; REGISTRATION; REVIEW; SIDE EFFECT; STOMACH ACID SECRETION; TREMOR; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; ASTHMA; DENMARK; DIABETES MELLITUS, TYPE 2; DRUG THERAPY; DRUG UTILIZATION REVIEW; EDUCATION, PHARMACY; FEMALE; HOUSE CALLS; HUMANS; INTERNSHIP, NONMEDICAL; INTERVIEWS; MALE; MIDDLE AGED; PATIENT EDUCATION; PATIENTS; PROFESSIONAL ROLE; STUDENTS, PHARMACY;

EID: 33750573488     PISSN: 09281231     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-006-9023-9     Document Type: Review

References (47)

1. van Mil JF, Westerlund LT, Hersberger KE, Schaefer MA. Drug-related problem classification systems. Ann Pharmacother 2004;38(5):859-67.
2. Kane MP, Briceland LL, Hamilton RA. Solving drug-related problems in the professional experience program. Am J Pharm Edu 1993;57:347-51.
3. Gordon W, Malyuk D, Taki J. Use of Health-Record Abstracting to Document Pharmaceutical Care Activities. Can J Hosp Pharm 2000;53(3):199-205.
4. Angaran DM. Quality assurance to quality improvement: measuring and monitoring pharmaceutical care. Am J Hosp Pharm 1991;48:1901-07.
5. Britten N. Lay views of drugs and medicines: orthodox and unorthodox accounts. In: Williams SJ, Calnan M, editors. Modern medicine-lay perspectives and experiences. London: UCL Press; 1996:48-73, ISBN-number: 18-572-831-8X.
6. Calnan M. Health and illness - the lay perspective. London, New York: Tavistock Publications; 1987, ISBN-number: 04-2279-420-1.
7. Fallsberg M. Reflections on medicines and medication - a qualitative analysis among people on long-term drug regimens. Linköping Studies in Education. Dissertations, 1991;31, ISBN-number: 91-7870-799-4.
8. Hansen EH, Launsø L. Drugs and users - problems and new directions. Health Promot 1988;3(3):241-8
9. Timm HU. Patienten i centrum? Brugerundersøgelser, lægperspektiver og kvalitetsudvikling. [Is the focus on the patient? User study, user perspective and quality improvement. In Danish]. DSI • Danish Institute for Health Services Research and Development; 1997, Report, ISBN-number: 87-7488-335-6.
10. Haugbølle LS, Devantier K, Frydenlund B. A user perspective on type-1 diabetes: sense of illness, search for freedom and the role of the pharmacy. Patient Educ Couns 2002;47:361-8.
11. Knudsen P, Hansen EH, Traulsen JM, Eskildsen K. Changes in self-concept while using SSRI antidepressants. Qual Health Res 2002;12(7):932-44.
12. Hassell K, Noyce P, Rogers A, Harris J, Wilkinson J. Advice provided in British community pharmacies: what people want and what they get. J Health Ser Res Policy 1998;3(4):219-25.
13. Stevenson FA, Barry CA, Britten N, Barber N, Bradley CP. Doctor-patient communication about drugs: the evidence for shared decision making. Soc Sci Med 2000;50:829-40.
14. Salmon P, Peters S, Stanley I. Patients' perceptions of medical explanations for somatisation disorders: qualitative analysis. BMJ 1999;318:372-6.
15. Adamsen L, Tewes M. Discrepancy between patient perspectives, staff's documentation and reflections on basic nursing care. Scand J Caring Sci 2000;14(2):120-9.
16. Klasen H, Goodman R, Goodman R. Parents and GPs at cross-purposes over hyperactivity: a qualitative study of possible barriers to treatment. Brit J Gen Prac 2000;50:199-202.
17. Haugbølle LS, Sørensen EW, Gundersen B, Petersen KH, Lorentzen L. Basing pharmacy counselling on the perspective of the angina pectoris patient. Phar World Sci 2002;24(2):71-8.
18. Paulino EK, Bouvy ML, Gastelurrutia MG, Guerreiro M, Buurma H. Drug related problems identified by European community pharmacists in patients discharged from hospital. Pharm World Sci 2004;26:353-60.
19. Titley-Lake C, Barber N. Drug related problems in the elders of the British Virgin Islands. Int J Pharm Pract 2000;8:53-9.
20. Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci 2003;25(5):218-26.
21. Australian Government - Department of Health and Ageing. Home Medicines Review. Available from https://www.health.gov/au/internet/wcms/publishing/nsf/ content/health-epc-ahmr.htm. Website viewed December 15th, 2005.
22. Haugbølle LS, Sørensen EW, Henriksen HH. Medication-and illness-related factual knowledge, perceptions and behaviour in angina pectoris patients. Patient Educ Couns 2002;47:281-9.
23. Sørensen EW, Haugbølle LS, Herborg H, Tomsen DV. Improving situated learning in pharmacy internship. Pharm Educ 2005;5(3/4):223-33.
24. Cornwall A, Jewkes R. What is participatory research? Soc Sci Med 1995;41(12):1667-76.
25. Gilbert AL, Roughead EE, Beilby J, Mott K, Barrarr JD. Collaborative medication management services: improving patient care. Med J Austr 2002;177:189-92.
26. Meijer WM, de Smit DJ, Jurgens RA, de Jong-van den Berg LTW. Pharmacists' role in improving awareness about folic acid: a pilot study on the process of introducing an intervention in pharmacy practice. Int J Pharm Pract 2004;12:29-35.
27. Anon. Managing care of angina patients in the community: a model of good pharmacy practice. Int Pharm J 1998;12(Suppl IV):2-4.
28. Churton M. Theory and method. London: Macmillan Press Ltd; 2000, ISBN-number: 033368110X.
29. Fallsberg M, Herborg HH, Væggemose U. How asthma patients think and act. Internal report. Denmark: Pharmakon; 1998.
30. Viney L, Westbrook M. Coping with chronic illness: strategy preferences, changes in preferences and associated emotional reactions. J Chron Dis 1984;37(6):489-502.
31. Antonovsky A. Unravelling the mystery of health. San Francisco: Jossey-Bass; 1987.
32. Lisper L, Isacson D, Sjödén PO, Bingefors K. Medicated hypertensive patients' views and experience of information and communication concerning antihypertensive drugs. Patient Educ Couns 1997;32:147-55.
33. Pharmakon. Forebyggelse af lægemiddelrelaterede problemer gennem apotekets ældre service [Preventing drug-related problems through the pharmacy's elder service project. In Danish]; 1997, Report.
34. Schaefer M. Basic principles for a coding system of drug-related problems: PI-Doc. Abstract at the International Working Conference on Outcome Measurements in Pharmaceutical Care; Pharmaceutical Care Network Europe January 26-29. Pharmakon, Danish College of Pharmacy Practice, Denmark; 1998.
35. Schaefer M. Discussing basic principles for a coding system of drug-related problems: the case of PI-Doc. Pharm World Sci 2002;24(4):120-7.
36. Enger K. NSDstat For Windows 95/98NT. Norsk amfundsvidenskabelig data-tjeneste [The Norwegian social science data service]; 1999.
37. Kvale S. Interviews - an introduction to qualitative research interviewing. Hans Reitzels Forlag: Copenhagen; 1996, ISBN-number: 08-0395-819-6.
38. Westerlund T, Almarsdóttir AB. Drug-related problems and pharmacy interventions in community practice. Int J Pharm Pract 1999;7:40-50.
39. Granås AG, Bates I. The effect of pharmaceutical review of repeat prescriptions in general practice. Int J Pharm Pract 1999;7:264-75.
40. Hugtenburg JG, Blom AThG, Gopie CTW, Beckeringh JJ. Communicating with patients the second time they present their prescription at the pharmacy - discovering patients' drug-related problems. Pharm World Sci 2004;26:328-32.
41. Emmerton L, Shaw J, Kheir N. Asthma management by New Zealand pharmacists: a pharmaceutical care demonstration project. J Clin Pharm Ther 2003;28:395-402.
42. Nilsson JLG, Andersson Å, Kälvemark S, Lieberman-Ram H, Ulenius B, Wendel A, et al. Surveys of drug-related therapy problems of patients using medicines for allergy, asthma and pain. Int J Pharm Pract 2000;8:198-203.
43. Blix HS, Viktil KK, Reikvam Å, Moger TA, Hjemaas BJ, Pretsch T, et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol 2004;60:651-8.
44. Westerlund T, Almarsdóttir AB, Melander A. Factors incluencing the detection rate of drug-related problems in community pharmacy. Pharm World Sci 1999;21(6):245-50.
45. Scwartzkoff J. Evaluation of the Home Medicines Review Program: pharmacy component. Canberra: Urbis Keys Young; 2005, ISBN.
46. Tully MP, Hassell K, Noyce P. Advice-giving in community pharmacies in the UK. J Health Serv Res Policy 1997;2:38-50.
47. Hepler CD, Strand LM. Oppontunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47(3): 533-43.